Population Impact of Generic Valsartan Recall

Cynthia A Jackevicius; Harlan M Krumholz; Alice Chong; Maria Koh; Aya F Ozaki; Peter C Austin; Jacob A Udell; Dennis T Ko

doi:10.1161/CIRCULATIONAHA.119.044494

Population Impact of Generic Valsartan Recall

Circulation. 2020 Feb 4;141(5):411-413. doi: 10.1161/CIRCULATIONAHA.119.044494. Epub 2019 Nov 11.

Authors

Cynthia A Jackevicius^{1

2

3

4

5}, Harlan M Krumholz^{6

7

8

9}, Alice Chong², Maria Koh², Aya F Ozaki^{1

3}, Peter C Austin^{2

4}, Jacob A Udell^{2

4

10}, Dennis T Ko^{2

4

11}

Affiliations

¹ Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA (C.A.J., A.F.O.).
² ICES, Toronto, Ontario, Canada (C.A.J., A.C., M.K., P.C.A., J.A.U., D.T.K.).
³ Veterans Affairs Greater Los Angeles Healthcare System, CA (C.A.J., A.F.O.).
⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada (C.A.J., P.C.A., J.A.U., D.T.K.).
⁵ University Health Network, Toronto, Ontario, Canada (C.A.J.).
⁶ Department of Medicine, Section of Cardiovascular Medicine (H.M.K.), Yale New Haven Hospital, CT.
⁷ Yale University School of Medicine, Center for Outcomes Research and Evaluation (H.M.K.), Yale New Haven Hospital, CT.
⁸ Department of Epidemiology and Public Health, Section of Health Policy and Administration, New Haven, CT (H.M.K.).
⁹ Robert Wood Johnson Foundation Clinical Scholars Program, New Haven, CT (H.M.K.).
¹⁰ Women's College Hospital, Toronto, Ontario, Canada (J.A.U.).
¹¹ Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (D.T.K.).

PMID: 31707798
DOI: 10.1161/CIRCULATIONAHA.119.044494

No abstract available

Keywords: angiotensin receptor antagonists; drug recalls; drug utilization; health services research; hypertension.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Angiotensin Receptor Antagonists / therapeutic use
Antihypertensive Agents / therapeutic use
Blood Pressure / drug effects*
Blood Pressure / genetics
Drugs, Generic / adverse effects*
Female
Humans
Hypertension / drug therapy*
Male
Middle Aged
Valsartan / adverse effects
Valsartan / pharmacology*

Substances

Angiotensin Receptor Antagonists
Antihypertensive Agents
Drugs, Generic
Valsartan

Grants and funding

FDN-154333/CIHR/Canada